SPECIFIC FEATURES IN THE TREATMENT OF UTERINE FIBROIDS- SURGERY VS. UTERINE ARTERY EMBOLIZATION

UTERINE LEIOMYOMAS OR “UTERINE FIBROIDS” ARE THE MOST COMMON BENIGN UTERINE TUMORS IN WOMEN OF REPORDUCTIVE AGE. USUALLY, THEY DEVELOP AS MULTIPLE SMALL TUMORS OR AS LARGE MASSES WITH DIFFERENT LOCATIONS RELATED TO THE LINING OF THE UTERUS. THE PATIENT HAS EITHER NO SYMPTOMS FOR A LONG PERIOD, OR SHE REPORTS HEAVY MENSTRUAL BLEEDING, PELVIC DISCOMFORT OR FERTILITY ISSUES. THERE IS A WIDE NUMBER OF TREATMENT OPTIONS, WHICH MUST BE ADAPTED TO EACH CASE, BUT THE MOST COMMON SOLUTION FOR LARGE SYMPTOMATIC TUMORS IS SURGERY. A NEWER ALTERNATIVE TO HISTERECTOMY OR MIOMECTOMY IS UTERINE ARTERY EMBOLIZATION. EACH OF THESE OPTIONS IS SUITED FOR A CERTAIN TYPE OF PATIENT, ACCORDING TO A SERIES OF CRITERIA. THESE PROCEDURES HAVE THEIR RIS KS AND BENEFITS, BUT THE PATIENT IS CONCERNED BY SUCH ASPECTS AS: PAIN LEVEL, HOSPITALIZATION PERIOD AND RECOVERY. THE FOLLOWING ARTICLE PRESENTS SPECIFIC ASPECTS ON THIS TOPIC ACCORDING TO OUR EXPERIENCE WITH UTERINE FIBROID TREATMENT IN THE UNIVERSITY EMERGENCY HOSPITAL BUCHAREST.

The body of this article is intentionally hidden on the public page. Please use the PDF reader or the PDF download for the complete text.